Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
clinical trials
diabetes
funding
fundings & exits
health
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
science
startups
tc
type 1 diabetes
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
apps
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
bessemer venture partners
bio
biotech ipos
boehringer ingelheim
bolt biotherapeutics
boston blog main
boston top stories
boulder/denver blog main
What
type
4
×
diabetes
drug
expect
medical
patients
startup
advantages
ago
app
approval
associates
attacks
bar
based
bessemer
bid
bio
boehringer
brings
called
capital
catalyst
caused
chat
competitor
data
deerfield
develop
developing
diagnosed
disease
diseases
domain
ear
eli
emergent
expand
faber
fallen
Language
unset
Current search:
type
×
biotech
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@techcrunch.com
5 years ago
RDMD attacks rare diseases with data mined from health records
@techcrunch.com
6 years ago
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes
